<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 140 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page139.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=140">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 140 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 140</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=140"><img src="../thumb/140.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.3.8                                                 2020-04 / 109
       incl pneumonit.& pulm.oed., anaphylact. reacts., palpitat., bronchosp.,   uraem., oligur., anur., ren.dysfunct., ac.ren.fail., impot., hepatit.,   Indications: Essent.hypertens.where pt. stabil. on indiv.compon.
       rhinit., sinusit., pulm.infiltrat., chest discomf., MI & CVA second. to   jaund., asthen., cough, bronchosp., rhinit., sinusit., skin reacts.incl.  at same dos.range.
       excess.hypotens.in high risk pts., ren. fail./ dysfunct., sympt.hypotens.,   pemphigus/tox. epiderm. necrolys./Stev.-John.syndr./erythema   (S3) TABS, A41/7.1.3/0633
       necrotis.angiit., skin reacts.incl.tox.epiderm.necrolys./erythem. multi-  multiforme, hypersens.reacts.& sympt.complex incl.poss. antinu-  714952-001: 30, R91,50
       forme/ Stev. Johns.syndr., alopec., bld. disords., xanthops., trans.blurr.  clear antibody, fac.angioed.  Dosage: 1 tab.once dly.in morn.bef.meal
       vis., gout &/ hyperuricaem. precip., electrol.imbal. incl. hyponatraem.,   Special precautions: Treatm.to be stopp.& chang. if pregn.oc-  Contraindications: Sulphon.sens., prev.ACE inhibit./ angiotens.
       sialoadenit., impot, hypersens. reacts. incl.angioed./sympt.compl.,   curs/pregn.contempl., cerebrovasc. /ischaem.heart dis., salt & vol.   recept.block.ther.angioed. hist., heredit./idiopath.angioed., aort.
       incr.liv.enzym./ cholester./ triglyceride lev., exacerbat./activat. SLE.  deplet. pts., ren.impairm., incr.ren.fail.risk esp in CHF, pt.at high risk   stenos., hypertroph. obstruct.cardiomyopathy, uncompens. card.fail.,
       Warnings and special precautions: Treatm.to be stopp.& switch.  of symptom.hypotens.to have condit. correct.bef.ther.& monit.when   sev.ren.funct.impairm. (creatinine clear.&lt;30 ml/min.), bil.ren.stenos.,
                                                                                         +
       to alter.meds.if pregn.occurs, use altern.meds.if pregn.contempl.,   init., bone marr. depress., diab.mellit., hyperkalaem., renovasc. dis./  ren. artery stenos.in pts.with sngl.kidn., concom. Li/ K spar. diuret./
       pass.through placenta, infts.of mothers who receiv.med., thiaz. excret.  hypertens., elderly, anaphylact. reacts. dur.hymenoptera desens.  supplem., porphyr., Addisons dis., hypokalaem., hepat.cirrhos., sev.liv.
       in breast milk, safety & effic.in childr.not est., ren.impairm., concom.   treatm.& dur. haemodialys. proced.with high flux membr./low-dens.  funct. impairm., pregn., lactat., safety & effic.in childr. not est., galact.
       Li not indic., incr. symptom. hypotens.risk, prior diuret.ther., ischaem.   lipoprot apheres.with dextr.sulf.absorpt., angioed.in black pts., por-  intol.hist./Lapp lact.defic/gluc.-galact. malabsorpt.
       heart / cerebrovasc.dis., hypotens., bilat./sngl.ren. art. stenos., vol./  phyr., maj.surg./dur. anaesthes., teratogenic./sev.toxic.in foet.&   Side effects: Bld.dyscras., orthostat.effs., hypotens., MI, cerebro-
       salt deplet., hepat.impairm./ progress. liv.dis., poss.anaphylactoid   newborn assoc.with expos.aft.1  trimest., cross. placenta, discont.  vasc.accid., palpitat., tachycard., chest pain, CNS effs., asthen., hy-
                                                  st
       reacts.in haemodialys.proced.using high-flux membran. & dur. de-  diuret.2-3 days bef.start.treatm. to minim.hypotens.risk, discont.ther.&   pokalaem., hyperkalaem., hyponatraem., rais. plasma Ca lev., pre-
       sensitisat., maj.surg./anaesth., anti-diab. meds., no re-challenge   init. emerg.treatm.in case of laryng.oed.which could be fatal, sev.  cipitat.second.gout, GI disturbs., pancreatit., impot., ren.dysfunct., ac
       aft.angioed.react., high. incid.of angioed.in black pts., monit.elec-  autoimmun.dis.esp.SLE/other collag. vasc.dis.& scleroderma, ac MI   ren. fail., hypochloraem.alkalos., oligour., anur., jaund., hepatit., musc.
       trolyt. when at risk, monit.ser.K  if K -supplem./K -spar. agents/K +    if ren.dysfunct. evid./ pt.at risk of furth.ser.haemodynam. deteriorat.   cramps, cough, bronchosp., rhinit., sinusit., prurit., urticar., diaphores.,
                            +
                    +
                       +
       -cont.salts used concom.      aft.treatm.with vasodilat., poss. discont.if ren.dysfunct.devel./hypo-  alopec., psorias., sev.skin disords. incl.tox. epiderm.necrolys./Stev.-
       Drug interactions: Incr.ser.K with K -supplem./ K -spar.agents /   tens.persist., bil. ren.artery stenos./arter.stenos.to sngl.kidn./ ren.  John.syndr.& erythema multiforme, photosens., hypersens./angioed.
                             +
                       +
                    +
       K -contain.salts esp.in imp.ren. funct., Li.clear.reduc., NSAID’s decr.  transplant, concom.immunosuppress.  reacts., vis.disturbs., sympt.complex report.incl. fev./ vasculit./myalg./
        +
       antihypertens. effic., incr.responsiv.to tubocurar., addit.eff.with other   Drug interactions: Add.antihypertens.eff.with diurets./ alcoh./  arthrit./arthralg. & posit. antinucl.antibod.
       antihypertens.agents., barbits./alcoh.& narcot. may potent.orthostat.  hypotens.-produc.meds., indomethacin & NSAID’s dimin.act., poss.   Special precautions: Cerebr.vasc.dis./ ischaem. heart dis., salt/
       hypotens., corticoster. & ACTH intens.electrol.deplet.& hypokalaem.,   hyperkalaem. with K -spar.diuret./K  supplem., Li conc.incr.  vol.deplet., ren.fail. induc. partic.with CHF, autoimmune dis.esp.SLE,
                                                    +
                                             +
       decr. respons.to pressor amin.  MYLAN CAPTOPRIL, Mylan [P/S]  other collag.vasc.dis., scleroderma, immunosuppress. pts., ac.MI,
       LISOZIDE, Austell             Captopril.                   ac.MI pts.at risk of furth. ser.haemodynam.deteriorat.aft.vasodilat.
       Lisinopril dihydrate 10(20)mg, hydrochlorothiazide 12,5 mg.  Indications: Mild to mod.hypertens., congest. heart fail.in combi-  treatm., bone marr.depress., diab.mellit., hyper-/hypokalaem., con-
                                                                                 +
                                                                           +
                                                                     +
       Indications: Mild to mod.hypertens.stabilis.on indiv. component.  nat.with diuret.&/digital.  com. K supplem./K -spar. diuret. /K  salt substit./meds.assoc.with
                                                                            +
                                                                   +
       giv.in same proport.          (S3) TABS. .29/7.1/0228, 32/7.1/0528  K lev. changes, monit.K lev.reg., renovasc.dis., ren. artery stenos.,
       (S3) TABS, A39/7.1.3/0108, 0109  852619-006: 25 mg, 60, R20,03  ren.funct.impairm., anaphylact. reacts. dur.hymenoptera desensiti-
       707292-001: 10/12,5 mg, 30, R53,40  899429-009: 50 mg, 60, R26,95  sat.treatm. /expos. to high flux membr.dialys./low-density lipoprot.
       707291-001: 20/12,5 mg, 30, R92,70  Dosage: Take 1 hr.bef.meals. Init. 25 mg 2-3xdly.incr.as necess.aft.2   apheres.with dextr.sulph.absorpt., angioed., high.angioed.incid.in
       Dosage: 1 tab once dly. Max 2 tabs once dly.if respons.inadeq.  wks.to 50 mg 3xdly. Max: 150 mg dly.  black pts., foet. abnormalit.report.aft. admin.in.pregn., sev. hepat.
       aft.2-4 wks.                  Heart fail: 6,25-12,5 mg 3xdly. Reduc.tot.dly.dos. aft.desir.re-  impairm., elderly, atheroscleros., hypotens., sev.card.insuffic./insul.
       Contraindications: Anur., hist.of angioed.with ACE-inhibit., heredit./  spons.achiev.  depend.diab. start ther.with low dos.or only 1 constit., maj. surg./
       idiopath angioed., sulphonam. sens., pregn.& lactat., aortic.stenos./   Contraindications: Pregn., safety in lactat.not est., safety & effic.   anaesthes., incr.tenden.to gout., posit. react. for athletes in drug tests
       hypertroph. cardiomyopathy, bilat./unilat.ren.artery stenos.in pres.of   in childr.not est., aort.stenos./ outfl.tract obstruct.  Drug interactions: Poss.incr.Li lev., hypoglycaem. eff.of insul.& hy-
       sngl.kidn., safety & effic.in childr. not est.  Side effects: Skin rash, persist.dry cough, taste disturbs., proteinur.  poglycaem.agents incr., baclofen potent.antihypertens.eff., ac.ren. in-
       Side effects: GI disturbs., headache, dry mouth, paraesthes., CNS   mainly in pts. with exist.rens. dis., bld.dyscras., angioed., tachycard.,   suffic.in dehydrat.pts.& concom.NSAIDS & high dos.salicylat., TCA’s/
       effs., sleep disturbs., mood alt., ment. confus., musc.cramp/spasm.,   headache, paraesthes., lymphadenopathy, photosens., stomatit., GI   neurolept./anaesth./diuret. / alcoh.& antihyperten.agents incr. anti-
       hyperglycaem., glycosur., jaund., pancreatit., hyperuricaem., hepatit.,   disturbs., hepatocell.effs., jaund., neutropen. esp.in pre-exist. imp.   hypertens. eff., corticoster.& tetracosactide reduc. antihypertens.eff.,
                                                                                 +
                                                                   +
                                                                               +
       dry cough., resp.distress.incl.pneumonit.& pulm. oed., anaphylact.re-  ren.funct., trans. hypotens. partic.in CHF pts., incr.K plasma conc.  K supplem./-spar. diuret. incr.K  lev., K  low.meds., allopurin./ cytostat/
       acts., palpitat., chest discomf., MI & CVA second.to excess.hypotens.  Special precautions: Imp.ren.funct.partic.if renovasc.dis.present,   immunosuppress./system.corticoster & procainamide incr.leucopen.
       in high risk pts., tachycard., hypotens.incl.orthostat. hypotens., vas-  collag.vasc.disord., ren. funct.to be assess.bef.admin., K-spar.diuret./   risk, non anti-arrhythm. drugs which prolong QT interv./cause torsades
       culit., ren.fail./dysfunct., skin reacts. incl. erythem. multiforme & tox.  meds. assoc.with incr.serum K, pass.through placenta, angioed.involv.  de pointes, NSAID’s & sympathomim. reduc. antihypertens. eff., card.
                                                                                +
       epiderm.necrolys., photosens., psorias., bld.disords., xanthops., trans.   extremit., pts.to report any S&S of infect., reg.WBC count esp.with   glycosides tox. effs.fav.by low.K lev., anti-arrhythm.drugs prod. tor-
       blurr. vis., gout, electrol.imbal.incl.hyponatraem.& hypercalcaem.,   imp. ren.funct./collag.vasc.dis & immunosuppress. ther., monit.high   sades de pointes as low K+ lev.are a risk fact. for arrythm, lact.aci-
       sialoadenit., impot, angioed., exacerbat./ activat.SLE.  risk pts.regular.for proteinur.  dos.with metformin, iodinat. contrast med.incr.risk of ac.ren.insuffic.
       Special precautions: Vol.& salt deplet., if poss. discont.diuret.  in pres. of dehydrat., reduc.urin.Ca eliminat.poss.incr. Ca lev.with Ca
       ther.2-3 days bef.init.treatm. otherwise admin.alone at init.dos.of   PEARINDA, Pharma Dynamics [P/S]  salts, ciclospor.may incr.creatinine lev., anticoags.eff.decr., nondepo-
       5 mg, ren./ hepat.impairm., monit.ser.K if concom.K -supplem. / K - +  Perindopril tert-butylamine  laris. neuromusc. block.agent block.enhanc.by hypokalaem. induct.
                       +
                             +
             +
       spar.diuret./K -contain.salts necess., anti-diab. meds., hypotens., elec-  Indications: Mild to mod.hypertens., CHF not adeq. control.with   PERINDOPRIL CO UNICORN 4/1,25, (Unicorn) Servier
       trol/fluid imbal., ischaem.heart dis., cerebrovasc.dis., poss.anaphylac-  diuret.& digital.& where vasodilat. indicat  Perindopril tertbutylamine salt 4 mg, indapamide 1,25 mg
       toid reacts in haemodialys.proced. using high-flux membran.& dur.  (S3) TABS, 41/7.1.3/0649, 0650  Indications: Essent.hypertens.not adeq.control. & where fix.com-
       desensitisat., maj. surg./anaesth., high.incid.of angioed.in black pts.  714527-001: 4 mg, 30, R77,94  binat.is consid.more approp.than monother.
                      +
                             +
       Drug interactions: K -supplem./K -spar.diuret./ K -contain.salts   714528-001: 8 mg, 30, R125,70  (S3) TABS, 37/7.1.3/0356
                 +
       esp.in ren.dysfunct.incr.serum K ., Li.clear.reduc., NSAID’s decr.anti-  Dosage: Mild to mod.hypertens: Start dos: 4 mg once dly., may   717782-001: 4 mg/1,25 mg, 30, R91,50
                    +
       hypertens.effic., incr.responsiv.to tubocurar., addit.eff.with other an-  be incr.to 8 mg once dly.aft.1 mnth. of treatm.if necess.  Dosage: Indiv.1 tab.dly.as sngl.dos.pref.in morn. bef. meal
       tihypertens.agents., alcoh./barbits.& narcot.may potent. orthostat.  CHF: Init. 2 mg as sngl.dos.in morn., may be incr. to 4 mg once dly.  Contraindications: Sulphon.sens., angioneurot. oed.hist.link.to
       hypotens.,corticoster.& ACTH intens.electrol.deplet.& hypokalaem.,   as maint.dos.  prev.ACE inhibit., sev.ren.fail., ser. liv. disord., hypokalaem., pregn.&
       decr. respons. to pressor amines.  Ren.insuffic: Adjust dos.in relat.to sev.thereof.  lactat., concom. Li/ K salts/-spar. diuret.& meds.caus. heart rhythm
                                                                           +
                                     Contraindications: Angioed.hist.assoc.with prev. ACE-inhibit.ther./
       LIZRO, Novagen [P/S]          angiotens.recept.block. ther., heredit./idiopath.angioed., aort.stenos.,   disords., bil.ren.artery stenos., sngl. funct.kidn., uncompens.card.fail.,
       Lisinopril.                   hypertroph.obstruct.cardiomyopathy, sev.ren. funct. impairm., bil./  safety & effic. in childr.not est.
       Indications: Mild to mod.hypertens.alone/ concom.other hypertens.,   sngl.ren.artery stenos., concom. K  spar.diuret.ther., porphyr., Ad-  Side effects: Angioneurot.oed., GI disturbs., dry mouth, hepat.en-
                                                   +
       adjunct in CHF.with diurets.& digital.where appropr., within 24 hrs.   dison’s dis., sulphonam.-deriv.med.hypersens., concom. Li, pregn.,   cephalopathy in pres.of hepat. insuffic., pancreatit., persist.dry cough,
       aft.ac.MI in haemodynamic.stable pts.  lactat., safety & effic.in childr.not est., galact. intol.hist./Lapp lact.  hypotens., hypersens./skin reacts.incl.ac. dissemin. lupus erythrema-
       (S3) TABS, A40/7.1.3/0722, 0723, 0724  defic/gluc.-galact. malabsorpt.  tos.aggrav., asthen., headache, dizzin., CNS eff., cramp, paraesthes.,
       714677-001: 5 mg, 30, R41,78  Side effects: Hypersens.reacts.incl.angioed.of face /extremit./lips/  bld.dyscras., anaem. in kidn.transpl./ haemodialys. pts., second.gout
       714678-001: 10 mg, 30, R41,69  tong./glottis & larynx., bld. dyscras., orthostat.effs., hypotens., MI/  precipitat., ren. fail.
       714679-001: 20 mg, 30, R78,85  CVA/ palpitat. & tachycard., CNS effs., hyperkalaem., hyponatraem.,   Special precautions: Pass.through placenta, discont. & switch.
       Dosage: Admin.as sngl.dly dos.pref.at the same time every day.  GI disords., dry mouth, pancreatit., impot., ren.insuffic.& ac.ren.fail.,   to diff.meds.should a woman become pregn., consid.altern.meds.if
       Mild to mod.hypertens: Init.10 mg/day as sngl. dos. Dos.should be   jaund., hepatit., asthen., musc.cramps, cough, dyspn., bronchosp.,   pregn. contempl., eval.risk/benef.in case of ren.impairm. esp. assoc.
       adjust.accord.to BP respons. Usual effect.maint.dos.is 20 mg/day as   rhinit., sinusit., skin rash incl.tox.epiderm. necrolys. /Stev.John.syn-  with immunosuppress.ther./collag. vasc. dis./scleroderma, discont.
       sngl.dos. Max. 40 mg/day. Full therapeut.eff.aft. sev.wks. theref.incr.  dr.& erythema multiforme, psorias., sweat., photosens., vis. disturbs.,   immed.in case of angioneurot. oed.& init.appropr.treatm., no re-chal-
       dos.aft.2-4  wks.if desir.respons.not achiev.  tinnit., sympt.complex.incl.posit. antinucl. antibod.  lenge aft.angioed.react., angioneurot.oed. hist. unrelat.to ACE inhibit.,
       Congest.heart fail: Init.2,5 mg dly.as sngl.dos. Incr.at 4 wk. in-  Special precautions: Cerebrovasc.dis., ischaem. heart dis., vol.&/  liv.funct.impairm., monit. Li-lev., start ther.with only 1 constit.in elder-
       terv.till therapeut.eff. Adjust accord. to clinic.respons. Maint.dos:   salt deplet., symptomat. hypotens., sev.autoimmune dis.esp. SLE/ oth-  ly/ creatin. clear.&gt;30 ml/min.but &lt;60 ml/ min./ ischaem.heart dis./
       5-20 mg/day as sngl.dos..     er collag. vasc.dis./scleroderma, ren. dysfunct., ac.MI, ac.MI where   cerebr.circulat.insuffic./ renovasc. hypertens./sev.card.insuffic.& insul.
       Ac.MI: 5 mg within 24 hrs.of sympt.onset. follow. by 5 mg aft.24 hrs.  risk of furth.ser. haemodynam. deteriorat.exists, bone marr. depress.,   depend. diab.mellit., electrol.disturbs., gout, hypotens., Na-free diets,
       then 10 mg aft.48 hrs. & then 10 mg dly.x6 wks. In case of low syst.  diab.mellit., hyperkalaem., meds. assoc. with incr.ser.K , renovasc.dis.,   kidn./heart fail., atheroscleros., ren.art./aort.stenos., hypovolaem.,
                                                           +
                                                                                         +
       BP (&lt;120mmHg) an init.dos.of 2,5 mg should be used dur.first 3 days   sngl./bilat. ren. artery stenos., ren.transplant, immunosuppress. ther.,   malnourish. pts., anaesthes./surg., cirrhot. pt.with oed., K  deplet.with
       aft.infarct. If hypotens.occurs (syst. BP &lt; 100 mmHg) admin.5 mg dly.  anaphylact.reacts.dur. hymenoptera desensitisat.treatm./expos.to   hypokalaem. risk, long QT-interv., adeq.hydrat., iodinat. contrast med.
       as maint. dos. with tempor.reduct.of 2,5 mg if need. Withdr. treatm.  high flux membr. dialys./low-density lipoprot. apheres. with dextr.  incr.risk of ac.ren.insuffic.in pres.of dehydrat., monit.ECG/ren.funct./
       if prolong.hypotens.(syst.BP &lt;90mmHg for more than 1 hr) occurs.  sulph.absorpt., incr.angioed. incid. in black pts., hyperkalaem.with K - +  K lev., concom. metformin., hypertroph.cardiomyopathy., mark. rais.
                                                                   +
       High risk indiv: Pts.on diuret: Init: 5 mg/day. Adjust accord.  spar. diuret. with poss.card.abnormalit., teratogen.(1  trimest. assoc.  Ca lev.poss.evid.of hyperparathyroid., bld. gluc. monit.in diab.pts.
                                                          st
       to respons.                   incr. CV & CNS birth defect risk)., elderly, monit.of concom.K -spar.  esp.if K lev.low, discont. treatm.in case of hepat. encephalopathy.
                                                                      +
                                                              +
       Renovasc.hypertens: Low.dos.to 2,5 or 5 mg.  diuret./K  supplem. /K  salt substit., surg./anaesthes.  Drug interactions: Poss.incr.Li lev., incr. hypoglycaem. eff.with
                                        +
                                              +
       Contraindications: Angioed.hist.relat.to prev. ACE inhibit./angio-  Drug interactions: Hypotens.eff.incr.by other antihypertens. pro-  insul./hypoglycaem. sulphonam., antihypertens.eff.incr./orthostat.
       tens.recept.block., heredit./ idiopath.angioed., aort.stenos., hyper-  duc.meds./alcohol & diuret., antihypertens. eff.reduc.by NSAID’s   hypotens. risk with baclofen/TCA’s/neurolept./ anaesth. agents/
       troph. obstruct. cardiomyopathy, sev.ren.funct.impairm., ren. artery   & indomethacin, poss.hyperkalaem.with K supplem. & K -spar.  NSAID’s & antihypertens., ac.ren. insuffic.in dehydrat.pts.& concom.
                                                       +
                                                              +
       stenos.in pts.with sngl.kidn., concom. K -spar.diuret., porphyr., safety   diuret., ser.Li incr.  NSAID’s/ high dos.salicylat., allopurin./cytostat./ immunosuppress.
                       +
       & effic.in childr. not est., pregn., safety in lactat.not est.  agents/syst.corticoster.& procainamide incr.leucopen.risk, reduc.urin.
       Side effects: Bld.dyscras., CV effs.incl.MI/CVA, CNS effs., paraes-  PEARINDA PLUS 4, Pharma Dynamics  Ca elimin. poss.incr.Ca lev., incr.potent.lethal K  lev. with K  spar.diu-
                                                                                          +
                                                                                      +
       thes., vertigo, hyperkalaem., hyponatraem., GI disturbs., pancreatit.,   Perindopril tert-butylamine salt 4 mg, indapamide 1,25 mg  rets.esp.in ren.insuffic., low K  lev. / bradycard.& pre-exist.long QT
                                                                               +</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page139.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page135.html">135</a>&nbsp;&nbsp;&nbsp;<a href="page136.html">136</a>&nbsp;&nbsp;&nbsp;<a href="page137.html">137</a>&nbsp;&nbsp;&nbsp;<a href="page138.html">138</a>&nbsp;&nbsp;&nbsp;<a href="page139.html">139</a>&nbsp;&nbsp;&nbsp;<a href="page140.html">140</a>&nbsp;&nbsp;&nbsp;<a href="page141.html">141</a>&nbsp;&nbsp;&nbsp;<a href="page142.html">142</a>&nbsp;&nbsp;&nbsp;<a href="page143.html">143</a>&nbsp;&nbsp;&nbsp;<a href="page144.html">144</a>&nbsp;&nbsp;&nbsp;<a href="page145.html">145</a>
             </td>
             <td width="35%"><a href="page141.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page141.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
